RecruitingNCT07216508
Liver Transplant CGM
Post-discharge Glycemic Control After Liver Transplant and Impact on Transplant Outcomes
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
40 participants
Start Date
Oct 13, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL
Exclusion Criteria4
- having a planned discharge to a rehabilitation or nursing facility,
- a contraindication to sensor placement,
- if discharge is anticipated to be \>30 days post-transplant, or
- if recent transplant also included a kidney or pancreas transplant
Interventions
DEVICELibre 3+
Blinded CGM will be worn by all participants
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07216508
Related Trials
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT0729648446 locations
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
NCT068364791 location
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location
High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes
NCT066884611 location
Exercise and Protein Efficiency in T2D
NCT074770671 location